The epidemiological data for Dengue has validated the alarming situation of dengue across the world, which in turn brings a huge population at the risk of dengue infection. Dengue virus (DENV) has ourserotypes, thus the generation of a single therapeutic to target all the 4 viruses can be challenging. The severity of this infection ranges from dengue fever and in extreme condition causes fatal haemorrhagic fever. Significant methods for preventing dengue transmission were vector control and dengue vaccination, both these methods will help in minimizing the quantum of disease. Novel techniques like using Wolbachia, Entomopathogenic fungi and genetically modified mosquitoes are successfully advancing in the direction for eliminating the Aedes aegypti and Aedes albopictus population. Moreover, clinical trials of dengue vaccines such as CYD-TD, LATV Δ 30 and DENVax are also showing promising results.
Keywords: Dengue virus; Preventions; Therapeutics; Dengue vaccines
Published on: Jul 7, 2017 Pages: 28-33
Full Text PDF
Full Text HTML
DOI: 10.17352/apm.000009
CrossMark
Publons
Harvard Library HOLLIS
Search IT
Semantic Scholar
Get Citation
Base Search
Scilit
OAI-PMH
ResearchGate
Academic Microsoft
GrowKudos
Universite de Paris
UW Libraries
SJSU King Library
SJSU King Library
NUS Library
McGill
DET KGL BIBLiOTEK
JCU Discovery
Universidad De Lima
WorldCat
VU on WorldCat
PTZ: We're glad you're here. Please click "create a new query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."